Log in
Log in
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     


Delayed Nyse  -  04:00:00 2023-03-21 pm EDT
0.6904 USD   +7.88%
03/20Asensus Surgical Says FDA Clears Expanded Indication for Senhance System
03/20Asensus Surgical Shares Rise on FDA Pediatric Nod for Senhance System
03/20Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System
Business Summary
Logo Asensus Surgical, Inc.
Asensus Surgical, Inc. is a medical device company that is digitizing the interface between the surgeon and the patient through Performance-Guided Surgery. The Company is focused on the market development and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital and multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits, such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation, including three-millimeter (mm) micro laparoscopic instruments, five mm articulating instruments, eye-sensing camera control and fully reusable standard instruments to patients around the world. Its Senhance System is used in Europe for adult and pediatric laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations. It is also available in the United States, Japan, Taiwan and Russia.

Number of employees : 197 people.
Sales per Business
Systems4.7457.6%2.5536% -46.22%
Instruments and Accessories1.9723.9%1.7825.1% -9.8%
Services1.5218.5%1.3719.4% -9.67%
USD in Million
Sales per region
United States0.7811%
USD in Million
Name Title Age Since
Anthony Fernando President Chief Executive Officer & Director 50 2019
Shameze Rampertab Chief Financial Officer & Executive Vice President 55 2020
Cameron Pedersen, Dr. Vice President-Global Research & Development - -
Motti Frimer VP-Digital Solutions, Research & Development - -
Mark Klausner Investor Relations Contact - -
Joshua B. Weingard Secretary & Chief Legal Officer 49 2013
Ethan Loiselle Vice President-Global Marketing - -
Edward Chekan Vice President-Medical Affairs - -
Nicholas Summit Senior Director-Strategy & Development - -
Amanda Owens Global Head-People - -
Members of the board
Name Title Age Since
David B. Milne Independent Chairman 59 2021
Richard C. Pfenniger Independent Director 66 2005
William N. Starling Independent Director 68 2006
Andrea Biffi Independent Director 40 2015
Kevin J. Hobert Independent Director 57 2021
Elizabeth Kwo, Dr. Independent Director - 2021
Anthony Fernando President Chief Executive Officer & Director 50 2019
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 239,279,746 234,371,293 97.9% 0 0.0% 97.9%
The Vanguard Group, Inc. 11,351,386 4.79%
First Trust Advisors LP 4,365,319 1.84%
BlackRock Fund Advisors 3,416,918 1.44%
Millennium Management LLC 2,275,852 0.96%
Geode Capital Management LLC 2,186,703 0.92%
Andrea Biffi 1,974,823 0.83%
Anthony Fernando 1,488,393 0.63%
Rafferty Asset Management LLC 1,456,254 0.61%
GSA Capital Partners LLP 968,036 0.41%
Sabby Management LLC 931,414 0.39%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Asensus Surgical, Inc.
Sector Other Medical Equipment, Supplies & Distribution
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration